Recent News View all news Jul 09, 2026 Labcorp Declares Quarterly Dividend Read more » Jun 30, 2026 Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 Read more » Jun 22, 2026 Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test Read more » May 29, 2026 Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer Read more » Events View all events Jul 30, 2026 at 9:00 AM EDT Q2 2026 Labcorp Holdings Inc. Earnings Conference Call Click Here for Webcast Jun 3, 2026 at 12:15 PM EDT Labcorp Holdings Inc. at the Jefferies Global Healthcare Conference in New York Click Here for Webcast May 21, 2026 at 9:00 AM EDT Labcorp Holdings Inc. Annual Shareholder Meeting Click Here for Webcast Financial Documents Current and historical annual reports and proxy statements View Documents SEC Filings View Labcorp’s annual filings, current reports and historic filings View Reports Corporate Governance Corporate management, board of directors and committee overview Learn moreabout corporate governance News & Events Press releases, news and events for investors News and Events Stock & Fundamentals Labcorp trading statistics, balance sheets, cash flow and income statements Fundamentals Contacts Investor Relations contact information Contact Information